ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE no for Pierre Fabre's Braftovi pharmatimes
September 17, 2020The National Institute for Health and Care Excellence has published the outcome of an appraisal of Pierre Fabre's Braftovi (encorafinib), turning down NHS funding for the drug as a treatment for some patients with advanced colorectal cancer.
Pharma Sources Insight January 2025
